Enfermedad linfoproliferativa difusa postrasplante renal: estudio longitudinal de 21.546 receptores durante 2 décadas en España

Enfermedad linfoproliferativa difusa postrasplante renal: estudio longitudinal de 21.546 receptores durante 2 décadas en España

Resumen: Introducción: La enfermedad linfoproliferativa difusa postrasplante (ELPD) es un grupo heterogéneo de enfermedades que se caracteriza por una proliferación de linfocitos después de un trasplante de órgano sólido y que presenta un espectro que comprende desde hiperplasias a agresivos linfom...

Full description

Bibliographic Details
Main Authors:	Antonio Franco, Domingo Hernandez, Sofia Zarraga, Ana Sanchez Fructuoso, Marta Crespo, Auxiliadora Mazuecos, Carmen Diaz Corte, Alberto Rodriguez Benot, Juan Carlos Ruiz, Isabel Beneyto
Format:	Article
Language:	Spanish
Published:	Elsevier 2023-07-01
Series:	Nefrología
Subjects:	Renal transplant recipient Post-transplant lymphoproliferative disorders Epstein-Barr virus
Online Access:	http://www.sciencedirect.com/science/article/pii/S0211699522000388

Similar Items

Lymphoproliferative disorders after renal transplantation along 2 decades: a large longitudinal study of 21.546 recipients
by: Antonio Franco, et al.
Published: (2023-07-01)

Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder
by: Mariam Markouli, et al.
Published: (2022-12-01)

Post-Transplant Lymphoproliferative Disorder: A Rare Case of CNS Involvement following Renal Transplant
by: Austin Feindt, et al.
Published: (2022-11-01)

Post-transplant lymphoproliferative disease
by: Nieto-Ríos, John Fredy, et al.
Published: (2016-07-01)

Isolated B cell central nervous system posttransplant lymphoproliferative disorder: Role of magnetic resonance imaging in the diagnosis and management in the absence of neurological signs - a case report
by: Monisha Jacob, et al.
Published: (2020-01-01)

Post-transplant lymphoproliferative disorder: Case reports of three children with kidney transplant
by: Spasojević-Dimitrijeva Brankica, et al.
Published: (2014-01-01)

Graft lymphoma in a kidney transplant recipient: a case report
by: Ji Hyun Yeom, et al.
Published: (2023-09-01)

Epstein–Barr virus infection in patients after hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01)

Facial ulceration in a renal transplant recipient
by: Gilles Absil, MD, et al.
Published: (2022-12-01)

Management of Epstein–Barr Virus Infection and Post-Transplant Lymphoproliferative Disorder in Pediatric Liver Transplantation
by: Tatsuya Okamoto, et al.
Published: (2022-04-01)

Post-transplant lymphoproliferative disease after pediatric kidney transplant
by: Rosanna Fulchiero, et al.
Published: (2022-12-01)

T cell posttransplant lymphoproliferative disorder after kidney transplantation progressing to acute liver failure: a case report
by: Jeong Min Cho, et al.
Published: (2023-12-01)

Natural Killer Cells in Post-Transplant Lymphoproliferative Disorders
by: Cecilia Nakid-Cordero, et al.
Published: (2021-04-01)

Management of post-transplant Epstein-Barr virus-related lymphoproliferative disease in solid organ and hematopoietic stem cell recipients
by: Heloisa Helena de Sousa Marques, et al.
Published: (2014-10-01)

The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation
by: Mohamed Ridha, et al.
Published: (2021-08-01)

Current Practices on Diagnosis, Prevention and Treatment of Post-Transplant Lymphoproliferative Disorder in Pediatric Patients after Solid Organ Transplantation: Results of ERN TransplantChild Healthcare Working Group Survey
by: Alastair Baker, et al.
Published: (2021-07-01)

Recent advances in the risk factors, diagnosis and management of Epstein-Barr virus post-transplant lymphoproliferative disease
by: Paibel Aguayo-Hiraldo, et al.
Published: (2016-01-01)

Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder
by: Süreyya Yiğit Kaya, et al.
Published: (2023-01-01)

Epstein-Barr virus induced post-transplant lymphoproliferative disorder presenting with unilateral retinal involvement
by: Mainguy Adam, et al.
Published: (2021-09-01)

Blastic Epstein-Barr virus associated post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for severe aplastic anemia
by: Masaaki Hotta, et al.
Published: (2018-05-01)

Host microRNAs are decreased in pediatric solid-organ transplant recipients during EBV+ Post-transplant Lymphoproliferative Disorder
by: Ayantika Sen, et al.
Published: (2022-10-01)

Posttransplant lymphoproliferative disorder coexisting with extrapulmonary tuberculosis: A diagnostic dilemma
by: Mohammed Shoeb Ahmed Khan, et al.
Published: (2018-01-01)

Desordem linfoproliferativa pós-transplante em paciente pediátrico Post-transplantation lymphoproliferative disorder in pediatric patient
by: Paulo Manuel Pêgo Fernandes, et al.
Published: (2006-10-01)

Case Report: Non-negligible Epstein-Barr virus-associated posttransplant lymphoproliferative disorders in a lung transplant recipient
by: Juan Hu, et al.
Published: (2023-09-01)

Nephropathic cystinosis in a kidney transplant recipient: A mesenteric lymph node demonstrates positive birefringent crystals
by: Trevor F. Killeen, et al.
Published: (2022-09-01)

First Report of an SH2D1A Mutation Associated with X-Linked Lymphoproliferative Disease in Turkey
by: Selman Kesici, et al.
Published: (2018-08-01)

EBV-Associated Lymphoproliferative Disorders
by: Young Hyeh Ko
Published: (2021-04-01)

CASE 2–2012: a 57-Year-Old Woman with Post-Transplant Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation for Primary Myelofibrosis
by: Milan Košťál, et al.
Published: (2012-01-01)

EBV Infection Associated Neoplastic Lesions and Imaging Characteristics
by: Tong YU, et al.
Published: (2022-08-01)

Post-transplant lymphoproliferative disorder risk and outcomes in renal transplant patients treated with belatacept immunosuppression
by: Jean L. Koff, et al.
Published: (2024-01-01)

Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options
by: Michele Clerico, et al.
Published: (2022-12-01)

Successful low‐dose chemotherapy for refractory Epstein‐Barr virus—related post‐transplant lymphoproliferative disorder following hematopoietic stem cell transplantation in a child with Wiskott‐Aldrich syndrome
by: Bixin Xi, et al.
Published: (2021-05-01)

Epstein–Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report
by: Ritika Dutta, et al.
Published: (2021-03-01)

A Rare Case of Classical Hodgkin Lymphoma Diagnosed 10 Years after Liver Transplant
by: L. Zhang, et al.
Published: (2017-10-01)

Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative Disease
by: Rebecca E. Schultze-Florey, et al.
Published: (2018-06-01)

Lymphoproliferative disorder during temozolomide therapy; a representative case of a formidable complication and management challenges
by: Daisuke Sato, et al.
Published: (2023-06-01)

Quantitative Analysis of Epstein-Barr Virus DNA Load in Bone Marrow Transplant Recipients By Using Real-Time PCR
by: Sabri SH., et al.
Published: (2005-09-01)

Quantitative Analysis of Epstein-Barr Virus DNA Load in Bone Marrow Transplant Recipients By Using Real-Time PCR
by: SH Sabri, et al.
Published: (2005-09-01)

Lymphoproliferative Syndrome in Pediatrist and Infectiologist Practice
by: E. N. Simovanyan, et al.
Published: (2010-06-01)

Methotrexate-Associated Lymphoproliferative Disorder: Dermoscopic Features
by: Takeshi Namiki, et al.
Published: (2018-05-01)